This project is devoted to test the hypothesis that brain tumors in high risk groups could be triggered by the presence of a germ line mutation in tumor suppressor genes, specifically in p53. The study will consist of screening several groups of pediatric and adult brain tumor patients including those with first degree relatives suffering from other malignancies, those with multiple primary neoplasms and infants under two years of age. Once the incidence of p53 germ line mutations in these high risk populations is determined, further studies will analyze the molecular and cellular evidence supporting or challenging the hypothesis that these mutations play an important role in the development of brain tumors in these selected populations.
| Weiner, H L; Rothman, M; Miller, D C et al. (1996) Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatr Neurosurg 25:64-71;discussion 71-2 |
| Zagzag, D; Friedlander, D R; Dosik, J et al. (1996) Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56:182-9 |
| Zagzag, D (1995) Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 146:293-309 |
| Zagzag, D; Friedlander, D R; Miller, D C et al. (1995) Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55:907-14 |
| Cordon-Cardo, C; Dalbagni, G; Saez, G T et al. (1994) p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer 56:347-53 |
